AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo.

AsiaTIDES 2019 keynote presentation lineup:

1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues
- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S

2) New Strategies and Technologies in Oligonucleotide Therapeutic Development
- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals

3) The Chemistry behind Approved Oligonucleotide Therapeutics
- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.

4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics
- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences

URLs:
Website https://go.evvnt.com/355503-0?pid=2874
Brochure https://go.evvnt.com/355503-3?pid=2874

Prices:
Conference Pass + Pre-Conference Workshop: USD 3023.0,
Conference Pass: USD 2375.0

Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences